Diagnosis of bloodstream infections in critically ill patients is difficult. This case control study involved a total of 22 patients with confirmed bloodstream infections and 44 concurrent controls from an intensive care unit in Western Australia. We aimed to assess whether eosinopenia and C-reactive protein are useful markers of bloodstream infections in critically ill patients. The patients with bloodstream infections had a more severe disease and a longer length of intensive care unit (10.7 vs 4.0 days, P=0.001) and hospital stay (40.9 vs 17.9 days, P=0.015) than the controls. Univariate analyses showed that C-reactive protein (area under the receiver operating characteristic curve 0.847, 95% confidence interval (CI) 0.721 to 0.973), eosinophil counts (area under the receiver operating characteristic curve 0.849, 95% CI 0.738 to 0.961) and fibrinogen concentrations (area under the receiver operating characteristic curve 0.730, 95% CI 0.578 to 0.882) were significant markers of bloodstream infections. C-reactive protein concentration was, however, the only significant predictor in the multivariate analysis (odds ratio 1.21 per 10 mg/l increment, 95% CI 1.01 to 1.39, P=0.007). C-reactive protein concentration appears to be a better marker of bloodstream infections than eosinopenia in critically ill patients. A large prospective cohort study is needed to assess whether eosinopenia is useful in addition to C-reactive protein concentrations as a marker of bloodstream infections.
Bloodstream infections are associated with significant mortality and morbidity, especially when appropriate antimicrobial therapy is delayed 1, 2 . Diagnosis of bloodstream infections based on clinical signs and symptoms alone is difficult and may delay appropriate antimicrobial therapy 3 . Blood cultures are the current gold standard in diagnosing bloodstream infections, but the process of obtaining a blood culture result is relatively slow, especially with a slow-growing micro-organism 4 . There is a rapid development in technology in diagnosing bloodstream infections in the past decade. For example, rapid detection of multiple microorganisms in bloodstream infections by real-time polymerase chain reaction (PCR) is now feasible 4, 5 .
The interpretation of the PCR results is, however, not straightforward when dealing with false positives and negatives 4 . Furthermore, the current PCR test also appears to be particularly insensitive to enterococcal bacteraemia 5 .
Eosinophils normally only account for a very small proportion of the peripheral white blood cells (1 to 3%) and this production is regulated by a number of mechanisms including many cytokines of acute inflammation [6] [7] [8] . While profound blood and tissue eosinophilia is a typical feature of parasitic helminth infection 8 , eosinopenia appears to be associated with bacterial infections including bloodstream infections 6, 7, 9, 10 . Whether eosinophil counts can be used a marker of bloodstream infections remains controversial 11 .
Some serum inflammatory markers such as C-reactive protein (CRP) concentrations have been reported to be a useful marker of bloodstream infections 12, 13 . Whether eosinopenia or a combination of eosinopenia and CRP can be used to predict bloodstream infections in critically ill patients remains uncertain. We hypothesised that eosinopenia and CRP can be used together to predict bloodstream infections in critically ill patients. We therefore conducted a case control study to assess whether eosinopenia and CRP concentrations are useful markers of bloodstream infections.
METHODS
The study was deemed to be a 'clinical audit' by the Hospital Ethics Committee and as such, formal human research ethics committee approval was not required.
A case control study design was used in this study because bloodstream infections were relatively uncommon in our intensive care unit (ICU). This case control study utilised the clinical database of the ICU of Royal Perth Hospital in Western Australia. The 22-bed tertiary ICU admits critically ill adult patients of all specialties except liver transplantation. In this study all patients with bloodstream infections were identified by the ICU clinical database as 'cases' if the ICU admission occurred between 1 January and 31 December, 2007 and the micro-organisms in the blood culture were also confirmed as pathological and not due to contamination. Patients with leucopenia (total white cell counts <4×10 9 /l) due to bone marrow suppression, either from a primary haematological disease or cytotoxic chemotherapy, were excluded in this study because eosinopenia is expected in these patients. Two controls, the patient who was admitted to the ICU immediately before and after the 'case', were selected concurrently for each bloodstream infection 'case'.
The inflammatory markers assessed in this study included C-reactive protein concentrations, fibrinogen concentrations, total white cell counts, neutrophil counts and eosinophil counts. The inflammatory markers of the cases and controls were obtained on the day of confirmed bloodstream infections or ICU admission, respectively. Eosinophil counts were determined by an automated method with minimal measurable eosinophil counts as 1×10 7 /l. Eosinophil counts less than 1×10 7 /l were not measurable and defined as eosinopenia in this study. Serum CRP concentrations were measured by an immunoenzyme analyser (Hitachi 917, Tokyo, Japan) and fibrinogen concentrations were measured using a method based on the Clauss technique (Diagnostica STAGO). All the laboratory tests were performed as part of the routine clinical practice.
Because the data of the inflammatory markers were not normally distributed, the association between different inflammatory markers and bloodstream infections was assessed by nonparametric Mann-Whitney test. We used the area under the receiver operating characteristic (ROC) curve to assess the predictive ability of the inflammatory markers in this study 14 . We also used the Acute Physiology and Chronic Health Evaluation (APACHE) II and admission Sequential Organ Failure Assessment (SOFA) scores to quantify the severity of acute illness of the cases and controls 15, 16 .
Markers associated with bloodstream infections in the univariate analyses with a P value of >0.10 were then further analysed by logistic regression analysis. The results of the multivariate analysis were first presented as a 'full model' without elimination of insignificant variables. As a sensitivity analysis, variables with a P value >0.05 in the 'full model' were progressively removed, in descending order of the associated P value, to assess whether a 'parsimony model' was different from the 'full model'. A P value of <0.05 was regarded as statistically significant and all statistical tests in this study were performed with SPSS for Windows (version 13.0 SPSS Inc. Il, USA, 2005).
RESUlTS
A total of 23 confirmed bloodstream infections (1.48%) were identified from the ICU clinical database for further analyses in 1557 ICU admissions in 2007. One patient was excluded because he had severe neutropenia (total white cell counts <1×10 9 /l) from chemotherapy at the time of bloodstream infections. Among the 22 cases of bloodstream infections included in this study, severe eosinopenia or an undetectable eosinophil count (counts=0) was observed on the day of bloodstream infections in 19 (86%) patients (mean eosinophil counts 0.04×10 9 /l, standard deviation [SD]=0.10). Sepsis accounted for about 23% of the control patients but eosinopenia (counts=0) only occurred in 2.3% of all the control patients (mean eosinophil counts 0.20×10 9 /l, SD=0.24). The clinical diagnosis, micro-organisms responsible for the bloodstream infections, CRP concentrations, eosinophil counts and total white cell counts of the cases are described in detail in Table 1 .
The basic demographic and clinical data of the cases and controls were comparable ( Table 2 ). The patients with bloodstream infections were, however, much sicker than the controls, as evidenced by a higher ICU admission APACHE II (24.2 vs 17.5, P <0.001) and SOFA score (10.5 vs 5.7, P <0.001). As expected, the patients with bloodstream infections were associated with a longer ICU (10.7 vs 4.0 days, P=0.001) and hospital stay (40.9 vs 17.9 days, P=0.015) than the controls ( Table 2) . (Tables 2 and 3 ).
In the multivariate analysis, a high CRP concentration was, however, the only significant marker associated with bloodstream infection (odds ratio 1.21 per 10 mg/l increment, 95% CI 1.01 to 1.39, P=0.007) ( Table 4 ). In the sensitivity analysis, the CRP concentrations remained as the only significant inflammatory marker associated with bloodstream infection (odds ratio 1.17 per 10 mg/l increment, 95% CI 1.06 to 1.29, P=0.001) suggesting that eosinopenia did not add significant diagnostic information to CRP concentrations.
Using an arbitrary CRP concentration >200 mg/l as a cut point, CRP had a high specificity (93%) but only a modest sensitivity (59%) for bloodstream infections. If we used another arbitrary CRP concentration >100 mg/l as a cut point, the sensitivity (82%) improved with a slightly lower specificity (70%).
DISCUSSION
To the best of our knowledge, this case control study is the first study that compared the ability of eosinopenia and CRP concentrations to predict bloodstream infections in critically ill patients. Our results showed that eosinopenia was very common in bloodstream infections but CRP was a better marker of bloodstream infections than eosinopenia. Eosinopenia also did not appear to give additional predictive information to CRP in predicting bloodstream infections in critically ill patients.
Although eosinophils account for only a very small proportion of the peripheral white blood cells, its production is tightly regulated by interleukin-3, interleukin-5 and granulocyte-macrophage colonystimulating factor [6] [7] [8] . Without these three cytokines, eosinophils survive for less than 48 hours 8 . These three cytokines are, however, not significantly activated in patients with bacterial or fungal sepsis 17 and as such, eosinopenia is expected in patients with severe sepsis and bloodstream infections 7, 9, 10 . Despite the relatively small sample size of our study, we could confirm that eosinopenia was in fact very common in patients with bloodstream infections 9, 10 and further showed that eosinopenia was a better marker of bloodstream infection than leucocytosis or an increase in neutrophil count alone (Table  3) 6 . These results suggest that eosinopenia can possibly be used as an additional warning test for bloodstream infections when only differential white cell counts are available.
Circulating CRP is an acute phase reactant exclusively produced by the liver, predominantly under transcriptional control by the cytokine interleukin-6 during infections and inflammation 18 . The CRP concentrations have been shown to correlate with plasma concentrations of interleukin-6 and organ dysfunction in critically ill patients [19] [20] [21] .
In a heterogeneous group of critically ill patients, the concentration of CRP falls as organ dysfunction resolves in survivors, but remains elevated in nonsurvivors 19 . Our results were consistent with a previous study showing that CRP could be a marker of bloodstream infections in neutropenic and nonneutropenic patients 12, 13 . Although eosinopenia has recently been reported 6 to be a more reliable marker than CRP in diagnosing sepsis in critically ill patients, our results suggest that CRP appears to be a better marker of bloodstream infections than eosinopenia in critically ill patients. There are at least two possible reasons why our results were different from this previous study. First, our study used bloodstream infections as an outcome whereas the previous study used clinical diagnosis of sepsis 6 .
A positive blood culture is a more specific and objective definition for an active infection than clinical diagnosis of sepsis. On the other hand, a positive blood culture is not a sensitive marker of severe sepsis as many severe infections can occur without a positive blood culture. Second, our patients were much sicker than the patients reported in the previous study (APACHE II score 24.2 vs 13.0) 6 . It is possible that bloodstream infections may induce a more significant generalised systemic inflammation than localised infections 17 . As such, it is possible that the relative ability of the CRP concentrations and eosinopenia in diagnosing different types of sepsis is different, depending on the severity of systemic inflammation and amount of chemotactic factors released into the systemic circulation. If our results can be further confirmed by a large prospective study, a high CRP concentration (e.g. >200 mg/l) in a critically ill patient may suggest further investigations, such as blood culture or real-time PCR testing, is needed to exclude bloodstream infections. This study has significant limitations. First, observational studies are prone to bias. Although the eosinophil counts were available in all patients, the CRP concentrations were available only in 17 of the bloodstream infections (77.3%). Missing data reduce the power of the study, and nonrandom missing data caused by selection bias may potentially create false positive results. Second, the number of bloodstream infections was small in this study and hence the statistical power was not strong. As such, the results of this study were imprecise. The sample size of this case control study had a power of 80% to demonstrate that eosinopenia was a significant marker of bloodstream infections only if the relative risk associated with eosinopenia was >14. Thus it is possible that our study might have underestimated the significance of eosinopenia in the multivariate analysis. Third, we had only one patient with candidaemia. Whether the ability of CRP concentrations and eosinopenia as a marker of fungaemia is different from that in bacteraemia remains uncertain, but this merits further investigation. Finally, many inflammatory markers have been reported to be associated with different outcomes of critically ill patients. For example, procalcitonin and soluble triggering receptor expressed on myeloid cell (sTREM)-1 concentrations have been shown to be very sensitive and specific in predicting sepsis and bacteraemia in critically ill patients [21] [22] [23] [24] . We have no data on the procalcitonin and sTREM-1 concentrations in our patients, and the performance of these inflammatory markers relative to the CRP concentrations and eosinopenia in predicting bloodstream infection in critically ill patients remains uncertain.
In summary, eosinopenia is very common in bloodstream infections. With the limited data available, CRP appears to be a better marker of bloodstream infection than eosinopenia. A large prospective cohort study is needed to confirm whether eosinopenia will give additional predictive information to CRP in critically ill patients with suspected bloodstream infection.
